Endurance Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Endurance Wealth Management's NVS Position: Q4 2020 in Review
Endurance Wealth Management sold out of Novartis (NVS) in Q4 2020, closing a stake of 290 shares — an estimated $25K sold.
Endurance Wealth Management first reported a position in NVS in Q1 2015 and held it in 23 quarters. The position peaked at $760K in Q2 2019. 1,177 funds tracked by Wall St. Rank hold NVS as of Q4 2020.
- Endurance Wealth Management reported no remaining Novartis position as of Q4 2020 after selling out during the quarter.
- Endurance Wealth Management sold 290 Novartis shares in Q4 2020, an estimated $25K.
- Endurance Wealth Management first reported a position in Novartis in Q1 2015 and held it in 23 quarters.
- Endurance Wealth Management's Novartis position peaked at $760K in Q2 2019.
- 1,177 funds tracked by Wall St. Rank held Novartis as of Q4 2020.
Based on Endurance Wealth Management's 13F filing for Q4 2020, filed 15 Jan 2021.